Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Predictors of Short- and Long-Term Mortality in Ischemic Stroke: A Community-Based Study in Brno, Czech Republic

T. Bryndziar, D. Matyskova, P. Sedova, S. Belaskova, M. Zvolsky, J. Bednarik, RD. Brown, R. Mikulik

. 2022 ; 51 (3) : 296-303. [pub] 20211117

Language English Country Switzerland

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc22019504

BACKGROUND AND OBJECTIVE: Short- and long-term mortality following ischemic stroke (IS) and their predictors have not been defined in the Czech population, and studies on long-term mortality are largely missing for the populations of Central Europe. METHODS: Using the National Register of Hospitalized Patients and the Czech National Mortality Registry, we analyzed data on 1-month, 1-year, and 3-year all-cause mortality for patients admitted with IS to any of the 4 hospitals with a certified stroke unit in Brno, Czech Republic, in 2011. We reviewed discharge summaries and recorded potential factors impacting mortality after the index stroke event. Using univariate and multivariable analyses, we identified predictors of mortality at all 3 time points. RESULTS: In our multivariable model, statin use (odds ratio [OR] 0.095, p < 0.0001), age at stroke (OR 1.03, p = 0.0445), and admission National Institutes of Health Stroke Scale (NIHSS) score (OR 1.16, p < 0.0001) predicted 1-month mortality, while statin use (OR 0.43, p = 0.0004), history of cardiac failure (OR 2.17, p = 0.0137), age at stroke (OR 1.07, p < 0.0001), and admission NIHSS score (OR 1.14, p < 0.0001) predicted 1-year mortality. Statin use (OR 0.54, p = 0.0051), history of cardiac failure (OR 2.13, p = 0.0206), age at stroke (OR 1.07, p < 0.0001), and admission NIHSS score (OR 1.11, p < 0.0001) also predicted 3-year mortality. CONCLUSIONS: Our study is the first to report data on short- and long-term mortality rates and their predictors in patients hospitalized with IS in the Czech population. Our results indicate that mortality rates and predictors of mortality are consistent with those reported in studies from other populations throughout the world.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22019504
003      
CZ-PrNML
005      
20250305101542.0
007      
ta
008      
220720s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.1159/000519937 $2 doi
035    __
$a (PubMed)34788769
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Bryndziar, Tomáš $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czechia $u Faculty of Medicine, Masaryk University, Brno, Czechia $u Department of Neurology, St. Anne's University Hospital, Brno, Czechia $7 xx0329563
245    10
$a Predictors of Short- and Long-Term Mortality in Ischemic Stroke: A Community-Based Study in Brno, Czech Republic / $c T. Bryndziar, D. Matyskova, P. Sedova, S. Belaskova, M. Zvolsky, J. Bednarik, RD. Brown, R. Mikulik
520    9_
$a BACKGROUND AND OBJECTIVE: Short- and long-term mortality following ischemic stroke (IS) and their predictors have not been defined in the Czech population, and studies on long-term mortality are largely missing for the populations of Central Europe. METHODS: Using the National Register of Hospitalized Patients and the Czech National Mortality Registry, we analyzed data on 1-month, 1-year, and 3-year all-cause mortality for patients admitted with IS to any of the 4 hospitals with a certified stroke unit in Brno, Czech Republic, in 2011. We reviewed discharge summaries and recorded potential factors impacting mortality after the index stroke event. Using univariate and multivariable analyses, we identified predictors of mortality at all 3 time points. RESULTS: In our multivariable model, statin use (odds ratio [OR] 0.095, p < 0.0001), age at stroke (OR 1.03, p = 0.0445), and admission National Institutes of Health Stroke Scale (NIHSS) score (OR 1.16, p < 0.0001) predicted 1-month mortality, while statin use (OR 0.43, p = 0.0004), history of cardiac failure (OR 2.17, p = 0.0137), age at stroke (OR 1.07, p < 0.0001), and admission NIHSS score (OR 1.14, p < 0.0001) predicted 1-year mortality. Statin use (OR 0.54, p = 0.0051), history of cardiac failure (OR 2.13, p = 0.0206), age at stroke (OR 1.07, p < 0.0001), and admission NIHSS score (OR 1.11, p < 0.0001) also predicted 3-year mortality. CONCLUSIONS: Our study is the first to report data on short- and long-term mortality rates and their predictors in patients hospitalized with IS in the Czech population. Our results indicate that mortality rates and predictors of mortality are consistent with those reported in studies from other populations throughout the world.
650    12
$a ischemie mozku $x komplikace $x diagnóza $x terapie $7 D002545
650    12
$a srdeční selhání $x komplikace $7 D006333
650    _2
$a lidé $7 D006801
650    12
$a statiny $7 D019161
650    12
$a ischemická cévní mozková příhoda $7 D000083242
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a rizikové faktory $7 D012307
650    _2
$a stupeň závažnosti nemoci $7 D012720
650    12
$a cévní mozková příhoda $x diagnóza $x epidemiologie $x terapie $7 D020521
651    _2
$a Česká republika $x epidemiologie $7 D018153
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Matyskova, Dominika $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czechia $u Faculty of Medicine, Masaryk University, Brno, Czechia
700    1_
$a Sedova, Petra $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czechia $u Faculty of Medicine, Masaryk University, Brno, Czechia $u Department of Neurology, St. Anne's University Hospital, Brno, Czechia $u Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA $u Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czechia
700    1_
$a Belaskova, Silvie $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czechia $u Institute of Mathematics and Statistics, Masaryk University, Brno, Czechia
700    1_
$a Zvolsky, Miroslav $u Institute for Health Information and Statistics of the Czech Republic, Prague, Czechia
700    1_
$a Bednarik, Josef $u Faculty of Medicine, Masaryk University, Brno, Czechia $u Department of Neurology, University Hospital Brno, Brno, Czechia
700    1_
$a Brown, Robert D $u Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA
700    1_
$a Mikulik, Robert $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czechia $u Faculty of Medicine, Masaryk University, Brno, Czechia $u Department of Neurology, St. Anne's University Hospital, Brno, Czechia
773    0_
$w MED00004935 $t Cerebrovascular diseases $x 1421-9786 $g Roč. 51, č. 3 (2022), s. 296-303
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34788769 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20250305101553 $b ABA008
999    __
$a ok $b bmc $g 1822908 $s 1170747
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 51 $c 3 $d 296-303 $e 20211117 $i 1421-9786 $m Cerebrovascular diseases $n Cerebrovasc Dis $x MED00004935
LZP    __
$a Pubmed-20220720

Find record

Citation metrics

Archiving options